Table 1 Genome-wide association studies and information of single nucleotide polymorphisms used as instrumental variable in the Mendelian randomization analyses of leukemia in relation to stroke
From: Leukemia and risk of stroke: a Mendelian randomization analysis
Traits | nSNPs | Ethnics | Sample size | Data sources | F-statistic (mean) | Reference |
|---|---|---|---|---|---|---|
Acute Lymphoblastic Leukemia | 23 | Europeans | 450,369 | UK Biobank | 23.24 | (L et al., 2021) |
Acute Myeloid Leukemia | 20 | Europeans | 453,144 | UK Biobank | 22.87 | (L et al., 2021) |
Chronic Lymphocytic Leukemia | 18 | Europeans | 451,228 | UK Biobank | 27.36 | (L et al., 2021) |
Chronic Myeloid Leukemia | 11 | Europeans | 454,486 | UK Biobank | 23.22 | (L et al., 2021) |